Grant: Engage Grants Program
McMaster University
$25,000.00
Formulation and optimization studies of spray-drying to prepare a thermally stabilized vaccine model
EF 2016-17
Résumé
Sanofi Pasteur, the vaccine division of Sanofi, is seeking to collaborate in a first-time research project with Dr.Michael Thompson of the Department of Chemical Engineering at McMaster University, to map effective waysof developing new formulations and processes by spray drying technology for thermally stable vaccines.Thermally stable vaccines constitute relatively new field of study, ushered forward as an identified globalchallenge for this century by the World Health Organization, NSF and the Melinda & Bill Gates Foundation.Many of our current vaccines are reliant upon storage and transport under uninterrupted refrigeration conditions(as low as -80°C), which hampers large scale stockpiling and restricts delivery. It is a multi-disciplinaryproblem requiring knowledge from Health Science and Natural Sciences & Engineering (NSE) to succeed; theproposal is solely focused on NSE contributions. The company needs to build knowledge in an approachgaining popularity in preparing thermally stable vaccines, where the viral vaccine platform is immobilized andencapsulated by a solid material(s) as it is spray dried into particles. The short-term project will research theeffectiveness of spray-drying at least ten formulations, of pure or blended solid matrices with a supplied viralvaccine by the company and characterizing the samples for particle properties and retained viral activity. Thechallenge is to produce particle-bound vaccine suitable for direct administration by inhalation and exhibitstorage stability at room temperature. The produced knowledge will strengthen the company's strategic productdevelopments, bolstering its competitiveness as a Canadian company and support Canada's health careinitiatives by allowing greater stockpiling of necessary vaccines, especially in times of pandemics like SARS.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
501989-2016
Name nom
Thompson, Michael
Department département
Chemical Engineering
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
1802
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Biochemical engineering
Research subject fr
Génie biochimique
Partie
1
Nb partie
1
Application title
Formulation and optimization studies of spray-drying to prepare a thermally stabilized vaccine model
Keyword
NSERC
Application summary
Sanofi Pasteur, the vaccine division of Sanofi, is seeking to collaborate in a first-time research project with Dr.Michael Thompson of the Department of Chemical Engineering at McMaster University, to map effective waysof developing new formulations and processes by spray drying technology for thermally stable vaccines.Thermally stable vaccines constitute relatively new field of study, ushered forward as an identified globalchallenge for this century by the World Health Organization, NSF and the Melinda & Bill Gates Foundation.Many of our current vaccines are reliant upon storage and transport under uninterrupted refrigeration conditions(as low as -80°C), which hampers large scale stockpiling and restricts delivery. It is a multi-disciplinaryproblem requiring knowledge from Health Science and Natural Sciences & Engineering (NSE) to succeed; theproposal is solely focused on NSE contributions. The company needs to build knowledge in an approachgaining popularity in preparing thermally stable vaccines, where the viral vaccine platform is immobilized andencapsulated by a solid material(s) as it is spray dried into particles. The short-term project will research theeffectiveness of spray-drying at least ten formulations, of pure or blended solid matrices with a supplied viralvaccine by the company and characterizing the samples for particle properties and retained viral activity. Thechallenge is to produce particle-bound vaccine suitable for direct administration by inhalation and exhibitstorage stability at room temperature. The produced knowledge will strengthen the company's strategic productdevelopments, bolstering its competitiveness as a Canadian company and support Canada's health careinitiatives by allowing greater stockpiling of necessary vaccines, especially in times of pandemics like SARS.